Jazz Pharmaceuticals Financials

Values in thousands	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$1,068,900	$1,197,926	$1,126,107	$1,045,712
Gross Profit	762,500	1,173,278	868,347	929,444
EBITDA	395,200	278,559	235,857	-514,182
EBIT	213,800	253,687	57,611	-688,191
Net Income	293,100	203,451	251,412	-718,470
Net Change In Cash	1,068,900	1,197,926	1,126,107	1,045,712
Free Cash Flow	388,500	296,789	459,441	100,888
Cash	1,844,300	1,391,899	1,236,070	1,189,880
Basic Shares	66,099	60,984	61,606	61,194

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$4,267,586	$4,068,950	$3,834,204	$3,659,374
Gross Profit	3,764,290	3,623,237	3,398,627	3,118,857
EBITDA	108,460	1,521,711	1,449,422	1,468,615
EBIT	-433,540	861,644	810,726	839,144
Net Income	-356,148	560,120	414,832	-224,060
Net Change In Cash	4,267,586	4,068,950	3,834,204	3,659,374
Cost of Revenue				296,256
Free Cash Flow	1,297,021	1,347,838	1,068,045	773,783
Cash	1,391,899	2,412,864	1,506,310	881,482
Basic Shares	60,984	66,007	72,066	62,539